Copy number alterations in pediatric B-cell precursor acute lymphoblastic leukemia patients and their association with patients’ outcome
Annals of Hematology · 2025
DOI: 10.1007/s00277-024-06102-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Hematology, 2025. Verfasst von Nesma E Abdelfattah und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pathology Department, National Cancer Institute, Cairo University, Kasr Al Eini Street, 4 Form El Khalig, Cairo, 11796, Egypt. Nesmaelsayed@…. Hauptthemen laut MEDLINE: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, DNA Copy Number Variations. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cairo University.
Abstract (Originalsprache)
Genetic abnormalities provide diagnostic and prognostic information for pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL) patients. The aim of this study was to determine the effects of genetic CNAs and RUNX1 gene abnormalities on the outcome of pediatric BCP-ALL patients. This study included 78 de novo-BCP-ALL pediatric patients who presented to the Pediatric Oncology Department of the National Cancer Institute (NCI), Cairo University. We aimed to study the impact of copy number alteration (CNA) of 8 of the most altered genes in BCP-ALL patients, in addition to RUNX1 gene abnormalities, on patient survival and response to treatment. Multiplex ligation-dependent probe amplification (MLPA) was used to detect CNA, while RUNX1 gene alterations were detected by fluorescence in situ hybridization (FISH). CNA of the PAX5 gene was significantly associated with worse overall survival (OS) and event-free survival (EFS) ( P = 0.012 and P = 0.025 , respectively). An increase in the CNA of ETV6 was associated with an increase in minimal residual disease (MRD) on day 15 (P = 0.041). Although RUNX1 gene abnormalities were not a predictor of shorter OS or EFS, an interesting significant association was found between PAX5 CNA and RUNX1 gene gain and translocation (P = 0.017 and P = 0.041, respectively). PAX5 CNA is an adverse prognostic factor. ETV6 CNA is associated with high MRD on day 15.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Pathology Department, National Cancer Institute, Cairo University, Kasr Al Eini Street, 4 Form El Khalig, Cairo, 11796, Egypt. Nesmaelsayed@cu.edu.eg.
- Clinical Pathology Department, National Cancer Institute, Cairo University, Kasr Al Eini Street, 4 Form El Khalig, Cairo, 11796, Egypt.
- Pediatric Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
ORCID-Profile: Nesma E Abdelfattah
Förderung
- Cairo University
Zitieren
APA
Abdelfattah, N. E., Elsayed, G. M., Soliman, A. H., Ebeid, E. N., & El Ashry, M. S. (2025). Copy number alterations in pediatric B-cell precursor acute lymphoblastic leukemia patients and their association with patients’ outcome. Annals of Hematology. https://doi.org/10.1007/s00277-024-06102-2
Vancouver
Abdelfattah NE, Elsayed GM, Soliman AH, Ebeid EN, El Ashry MS. Copy number alterations in pediatric B-cell precursor acute lymphoblastic leukemia patients and their association with patients’ outcome. Annals of Hematology. 2025. doi:10.1007/s00277-024-06102-2
BibTeX
@article{Abdelfattah2025,
author = {Abdelfattah, Nesma E and Elsayed, Ghada M and Soliman, Amira H and Ebeid, Emad N and El Ashry, Mona S},
title = {Copy number alterations in pediatric B-cell precursor acute lymphoblastic leukemia patients and their association with patients’ outcome},
journal = {Annals of Hematology},
year = {2025},
doi = {10.1007/s00277-024-06102-2}
}
EUVIMED